Steven C Ghivizzani,
Professor
Department:
MD-ORTHOPAEDICS / REHAB
Business Phone:
(352) 273-7059
Business Email:
ghivisc@ortho.ufl.edu
Teaching Profile
Courses Taught
2020-2021
GMS6252 Molecular Therapy II – Disease Targets and Applications
2018
EML7980 Research for Doctoral Dissertation
2014
GMS6331 Stem Cell Biology
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0001-5154-7581
Publications
Academic Articles
2024
Osteoblast Growth in Quaternized Silicon Carbon Nitride Coatings for Dental Implants.
Materials (Basel, Switzerland).
17(21)
[DOI] 10.3390/ma17215392.
[PMID] 39517666.
2024
The 2024 OREF Clinical Research Award: Progress Toward a Gene Therapy for Arthritis.
The Journal of the American Academy of Orthopaedic Surgeons.
32(23):1052-1060
[DOI] 10.5435/JAAOS-D-24-00831.
[PMID] 39284030.
2024
Toxic effects of local anesthetics on rat fibroblasts: An in-vitro study.
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.
[DOI] 10.1016/j.jos.2024.04.003.
[PMID] 38670825.
2023
Osteoarthritis gene therapy in 2022.
Current opinion in rheumatology.
35(1):37-43
[DOI] 10.1097/BOR.0000000000000918.
[PMID] 36508307.
2022
Effect of Silicon Carbide Coating on Osteoblast Mineralization of Anodized Titanium Surfaces.
Journal of functional biomaterials.
13(4)
[DOI] 10.3390/jfb13040247.
[PMID] 36412888.
2022
Gene Therapy in Orthopaedics: Progress and Challenges in Pre-Clinical Development and Translation.
Frontiers in bioengineering and biotechnology.
10
[DOI] 10.3389/fbioe.2022.901317.
[PMID] 35837555.
2021
Fast SARS-CoV-2 virus detection using disposable cartridge strips and a semiconductor-based biosensor platform.
Journal of vacuum science and technology. B, Nanotechnology & microelectronics : materials, processing, measurement, & phenomena : JVST B.
39(3)
[DOI] 10.1116/6.0001060.
[PMID] 34055475.
2021
Orthopaedic Gene Therapy: Twenty-Five Years On.
JBJS reviews.
9(8)
[DOI] 10.2106/JBJS.RVW.20.00220.
[PMID] 34437305.
2018
Arthritis Gene Therapy Approved in Korea.
The Journal of the American Academy of Orthopaedic Surgeons.
26(2):e36-e38
[DOI] 10.5435/JAAOS-D-17-00695.
[PMID] 29303924.
2018
Arthritis gene therapy is becoming a reality.
Nature reviews. Rheumatology.
14(7):381-382
[DOI] 10.1038/s41584-018-0009-5.
[PMID] 29743627.
2018
Gene Delivery to Joints by Intra-Articular Injection.
Human gene therapy.
29(1):2-14
[DOI] 10.1089/hum.2017.181.
[PMID] 29160173.
2018
Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine Model.
Human gene therapy. Clinical development.
29(2):90-100
[DOI] 10.1089/humc.2017.142.
[PMID] 29869540.
2018
Gene Therapy to Enhance Bone and Cartilage Repair in Orthopaedic Surgery.
Current gene therapy.
18(3):154-170
[DOI] 10.2174/1566523218666180410152842.
[PMID] 29637858.
2018
Lentiviral-based reporter constructs for profiling chondrogenic activity in primary equine cell populations.
European cells & materials.
36:156-170
[DOI] 10.22203/eCM.v036a12.
[PMID] 30311630.
2018
Self-Complementary Adeno-Associated Virus-Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis: Test of Efficacy in an Equine Model.
Human gene therapy. Clinical development.
29(2):101-112
[DOI] 10.1089/humc.2017.143.
[PMID] 29869535.
2016
Liquid-like Solids Support Cells in 3D.
ACS biomaterials science & engineering.
2(10):1787-1795
[DOI] 10.1021/acsbiomaterials.6b00218.
[PMID] 33440476.
2016
MAGNETIC RESONANCE IMAGING SCORING OF AN EXPERIMENTAL MODEL OF POST-TRAUMATIC OSTEOARTHRITIS IN THE EQUINE CARPUS.
Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
57(5):502-14
[DOI] 10.1111/vru.12369.
[PMID] 27198611.
2014
Animal models in osteosarcoma.
Frontiers in oncology.
4
[DOI] 10.3389/fonc.2014.00189.
[PMID] 25101245.
2014
Magnetic Resonance Imaging Scoring of An Experimental Model of Osteoarthritis in the Equine Carpus
.
22(S)
2013
Arthritis gene therapy and its tortuous path into the clinic.
Translational research : the journal of laboratory and clinical medicine.
161(4):205-16
[DOI] 10.1016/j.trsl.2013.01.002.
[PMID] 23369825.
2013
Directed Evolution of Aav Capsid for Targeted Cancer Therapy
Molecular Therapy.
21
2013
Scaav Provides Sustained Expression of a Homologous Therapeutic Transgene in Large Mammalian Joints, With Enhanced Expression in Osteoarthritis
Molecular Therapy.
21
2013
scAAV-mediated gene transfer of interleukin-1-receptor antagonist to synovium and articular cartilage in large mammalian joints.
Gene therapy.
20(6):670-7
[DOI] 10.1038/gt.2012.81.
[PMID] 23151520.
2012
An acidic oligopeptide displayed on AAV2 improves axial muscle tropism after systemic delivery.
Genetic vaccines and therapy.
10(1)
[DOI] 10.1186/1479-0556-10-3.
[PMID] 22709483.
2012
Indian hedgehog gene transfer is a chondrogenic inducer of human mesenchymal stem cells.
Arthritis research & therapy.
14(4)
[DOI] 10.1186/ar3921.
[PMID] 22817660.
2012
Orthopedic gene therapy–lost in translation?
Journal of cellular physiology.
227(2):416-20
[DOI] 10.1002/jcp.23031.
[PMID] 21948071.
2011
Evidence for the osteosarcoma stem cell.
Current orthopaedic practice.
22(4):322-326
[PMID] 21755019.
2011
Getting arthritis gene therapy into the clinic.
Nature reviews. Rheumatology.
7(4):244-9
[DOI] 10.1038/nrrheum.2010.193.
[PMID] 21135882.
2010
Gene delivery of TGF-β1 induces arthrofibrosis and chondrometaplasia of synovium in vivo.
Laboratory investigation; a journal of technical methods and pathology.
90(11):1615-27
[DOI] 10.1038/labinvest.2010.145.
[PMID] 20697373.
2009
Chondrogenesis of Bovine Mscs Is Influenced By Adenoviral-Mediated Delivery of Bmp-4, Bmp-7, Indian Hedgehog, and Sox-9
Molecular Therapy.
17
2009
Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis.
Human gene therapy.
20(2):97-101
[DOI] 10.1089/hum.2008.075.
[PMID] 18986219.
2009
Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer.
Tissue engineering. Part A.
15(5):1127-39
[DOI] 10.1089/ten.tea.2007.0252.
[PMID] 18826340.
2009
Examining the Role of Elevated Blood Glucose in the Severity of Arthrofibrosis Using Intra-Articular Gene Delivery of Tgf-Beta 1
Molecular Therapy.
17
2009
Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma.
Cancer research.
69(14):5648-55
[DOI] 10.1158/0008-5472.CAN-08-3580.
[PMID] 19584295.
2009
Gene therapy of the rheumatic diseases: 1998 to 2008.
Arthritis research & therapy.
11(1)
[DOI] 10.1186/ar2563.
[PMID] 19232068.
2009
Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer.
Arthritis research & therapy.
11(5)
[DOI] 10.1186/ar2822.
[PMID] 19799789.
2009
Intra-articular gene delivery and expression of interleukin-1Ra mediated by self-complementary adeno-associated virus.
The journal of gene medicine.
11(7):605-14
[DOI] 10.1002/jgm.1334.
[PMID] 19384892.
2009
Orthopedic gene therapy in 2008.
Molecular therapy : the journal of the American Society of Gene Therapy.
17(2):231-44
[DOI] 10.1038/mt.2008.265.
[PMID] 19066598.
2009
Progress and Prospects: genetic treatments for disorders of bones and joints.
Gene therapy.
16(8):944-52
[DOI] 10.1038/gt.2009.73.
[PMID] 19675584.
2009
Transduction of Equine Joint Tissues With Self-Complementary Adeno-Associated Virus
Molecular Therapy.
17
2008
A simple, lanthanide-based method to enhance the transduction efficiency of adenovirus vectors.
Gene therapy.
15(5):357-63
[DOI] 10.1038/sj.gt.3303092.
[PMID] 18283289.
2008
Arthritis gene therapy’s first death.
Arthritis research & therapy.
10(3)
[DOI] 10.1186/ar2411.
[PMID] 18510784.
2008
Perspectives on the use of gene therapy for chronic joint diseases.
Current gene therapy.
8(4):273-86
[PMID] 18691023.
2008
Reduction in severity of a herpes simplex virus type 1 murine infection by treatment with a ribozyme targeting the UL20 gene RNA.
Journal of virology.
82(15):7467-74
[DOI] 10.1128/JVI.02720-07.
[PMID] 18508896.
2007
[Gene therapy for osteoarticular disorders].
Medecine sciences : M/S.
23(3):303-9
[PMID] 17349293.
2007
Facilitated endogenous repair: making tissue engineering simple, practical, and economical.
Tissue engineering.
13(8):1987-93
[PMID] 17518747.
2007
Genetically enhanced engineering of meniscus tissue using ex vivo delivery of transforming growth factor-beta 1 complementary deoxyribonucleic acid.
Tissue engineering.
13(9):2227-37
[PMID] 17561802.
2007
Major biological obstacles for persistent cell-based regeneration of articular cartilage.
Arthritis research & therapy.
9(3)
[PMID] 17561986.
2007
Transgene persistence and cell turnover in the diarthrodial joint: implications for gene therapy of chronic joint diseases.
Molecular therapy : the journal of the American Society of Gene Therapy.
15(6):1114-20
[PMID] 17440444.
2006
Exogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1beta.
Arthritis research & therapy.
8(6)
[PMID] 17109745.
2006
Gene therapeutic approaches-transfer in vivo.
Advanced drug delivery reviews.
58(2):243-58
[PMID] 16563557.
2006
Gene therapy for arthritis: what next?
Arthritis and rheumatism.
54(6):1714-29
[PMID] 16729280.
2006
Will arthritis gene therapy become a clinical reality?
Nature clinical practice. Rheumatology.
2(7):344-5
[PMID] 16932715.
2005
Dual transduction of insulin-like growth factor-I and interleukin-1 receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
23(1):118-26
[PMID] 15607883.
2005
Gene therapy for the treatment of musculoskeletal diseases.
The Journal of the American Academy of Orthopaedic Surgeons.
13(4):230-42
[PMID] 16112980.
2005
Gene transfer to human joints: progress toward a gene therapy of arthritis.
Proceedings of the National Academy of Sciences of the United States of America.
102(24):8698-703
[PMID] 15939878.
2005
Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro.
Molecular therapy : the journal of the American Society of Gene Therapy.
12(2):219-28
[PMID] 16043093.
2005
Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy.
Gene therapy.
12(2):177-86
[PMID] 15578043.
2005
Stem-like cells in bone sarcomas: implications for tumorigenesis.
Neoplasia (New York, N.Y.).
7(11):967-76
[PMID] 16331882.
2005
The 3rd International Meeting on Gene Therapy in Rheumatology and Orthopaedics.
Arthritis research & therapy.
7(6):273-8
[PMID] 16277703.
2004
Adenovirus-mediated gene transfer of glutamine: fructose-6-phosphate amidotransferase antagonizes the effects of interleukin-1beta on rat chondrocytes.
Osteoarthritis and cartilage.
12(3):217-24
[PMID] 14972338.
2004
Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
22(1):66-72
[PMID] 14656661.
2004
Gene delivery to cartilage defects using coagulated bone marrow aspirate.
Gene therapy.
11(2):133-41
[PMID] 14712297.
2004
Gene-based approaches for the repair of articular cartilage.
Gene therapy.
11(4):351-9
[PMID] 14724680.
2004
In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors.
Methods in molecular medicine.
100:147-64
[PMID] 15280594.
2004
Osteoarthritis gene therapy.
Gene therapy.
11(4):379-89
[PMID] 14724685.
2004
The 2003 Nicolas Andry Award. Orthopaedic gene therapy.
Clinical orthopaedics and related research.
(429):316-29
[PMID] 15577504.
2003
A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer.
Arthritis research & therapy.
5(5):R301-9
[PMID] 12932294.
2003
Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees.
Arthritis research & therapy.
5(3):R132-9
[PMID] 12723985.
2003
Gene transfer to articular chondrocytes with recombinant adenovirus.
Methods in molecular biology (Clifton, N.J.).
215:235-46
[PMID] 12512303.
2003
Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium.
Gene therapy.
10(12):1055-60
[PMID] 12776164.
2003
Lentiviral-mediated gene delivery to synovium: potent intra-articular expression with amplification by inflammation.
Molecular therapy : the journal of the American Society of Gene Therapy.
7(4):460-6
[PMID] 12727108.
2002
Delivery of plasmid DNA to articular chondrocytes via novel collagen-glycosaminoglycan matrices.
Human gene therapy.
13(7):791-802
[PMID] 11975846.
2002
Development of gene-based therapies for cartilage repair.
Critical reviews in eukaryotic gene expression.
12(4):259-73
[PMID] 12641395.
2002
Gene transfer approaches to the healing of bone and cartilage.
Molecular therapy : the journal of the American Society of Gene Therapy.
6(2):141-7
[PMID] 12161179.
2002
Genetic approaches to the repair of connective tissues.
Annals of the New York Academy of Sciences.
961:65-7
[PMID] 12081867.
2002
Genetic approaches to tissue engineering: breakout session summary.
Annals of the New York Academy of Sciences.
961:71-2
[PMID] 12081869.
2002
In organello footprinting of mtDNA.
Methods in molecular biology (Clifton, N.J.).
197:363-75
[PMID] 12013810.
2002
In vivo gene delivery to synovium by lentiviral vectors.
Molecular therapy : the journal of the American Society of Gene Therapy.
5(4):397-404
[PMID] 11945066.
2002
Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene.
Gene therapy.
9(1):12-20
[PMID] 11850718.
2001
Direct gene delivery strategies for the treatment of rheumatoid arthritis.
Drug discovery today.
6(5):259-267
[PMID] 11182599.
2001
Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4.
Journal of immunology (Baltimore, Md. : 1950).
166(5):3499-505
[PMID] 11207309.
2001
Future of adenoviruses in the gene therapy of arthritis.
Arthritis research.
3(3):142-6
[PMID] 11299054.
2001
Gene therapy for rheumatoid arthritis.
Current rheumatology reports.
3(1):79-85
[PMID] 11177774.
2001
Gene therapy for rheumatoid arthritis.
Expert opinion on biological therapy.
1(6):971-8
[PMID] 11728228.
2001
Gene therapy for rheumatoid arthritis.
Hand surgery : an international journal devoted to hand and upper limb surgery and related research : journal of the Asia-Pacific Federation of Societies for Surgery of the Hand.
6(2):211-9
[PMID] 11901469.
2001
Gene transfer of p53 to arthritic joints stimulates synovial apoptosis and inhibits inflammation.
Molecular therapy : the journal of the American Society of Gene Therapy.
3(6):901-10
[PMID] 11407904.
2001
The effect of bone morphogenetic protein-2 expression on the early fate of skeletal muscle-derived cells.
Bone.
28(5):499-506
[PMID] 11344049.
2000
Adenoviral mediated delivery of FAS ligand to arthritic joints causes extensive apoptosis in the synovial lining.
The journal of gene medicine.
2(3):210-9
[PMID] 10894267.
2000
Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints.
Arthritis and rheumatism.
43(11):2563-70
[PMID] 11083281.
2000
Cartilage injury and repair.
Physical medicine and rehabilitation clinics of North America.
11(2):289-307, vi
[PMID] 10810762.
2000
Clinical trials in the gene therapy of arthritis.
Clinical orthopaedics and related research.
(379 Suppl):S300-7
[PMID] 11039783.
2000
Ex vivo gene therapy to produce bone using different cell types.
Clinical orthopaedics and related research.
(378):290-305
[PMID] 10987005.
2000
Gene therapy approaches for treating rheumatoid arthritis.
Clinical orthopaedics and related research.
(379 Suppl):S288-99
[PMID] 11039782.
2000
Gene therapy for autoimmune disorders.
Journal of clinical immunology.
20(5):334-46
[PMID] 11051275.
2000
Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4.
Arthritis research.
2(4):293-302
[PMID] 11056670.
2000
Gene therapy for rheumatoid arthritis.
Clinical orthopaedics and related research.
(379 Suppl):S308-10
[PMID] 11039784.
2000
Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene.
Gene therapy.
7(9):734-9
[PMID] 10822299.
2000
Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1.
Arthritis and rheumatism.
43(5):1156-64
[PMID] 10817570.
2000
Potential applications of gene therapy in sports medicine.
Physical medicine and rehabilitation clinics of North America.
11(2):405-16
[PMID] 10810768.
2000
Potential role of direct adenoviral gene transfer in enhancing fracture repair.
Clinical orthopaedics and related research.
(379 Suppl):S120-5
[PMID] 11039760.
2000
The efficiency of muscle-derived cell-mediated bone formation.
Cell transplantation.
9(4):463-70
[PMID] 11038063.
2000
The Marshall R. Urist Young Investigator Award. Orthopaedic applications of gene therapy. From concept to clinic.
Clinical orthopaedics and related research.
(375):324-37
[PMID] 10853185.
2000
Using gene therapy to protect and restore cartilage.
Clinical orthopaedics and related research.
(379 Suppl):S214-9
[PMID] 11039771.
2000
Vector systems for gene transfer to joints.
Clinical orthopaedics and related research.
(379 Suppl):S17-30
[PMID] 11039748.
1999
Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro.
Diabetes.
48(9):1730-6
[PMID] 10480601.
1999
Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone.
Bone.
24(6):541-7
[PMID] 10375195.
1999
Clinical gene therapy for arthritis.
Drugs of today (Barcelona, Spain : 1998).
35(4-5):389-96
[PMID] 12973441.
1999
Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees.
Journal of immunology (Baltimore, Md. : 1950).
163(4):2202-8
[PMID] 10438962.
1999
Gene therapy for rheumatic diseases.
Arthritis and rheumatism.
42(1):1-16
[PMID] 9920008.
1999
Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis.
Gene therapy.
6(10):1713-20
[PMID] 10516720.
1999
Lessons learned from gene transfer approaches.
Arthritis research.
1(1):21-4
[PMID] 11094409.
1999
The role of gene therapy. Fact or fiction?
Clinics in sports medicine.
18(1):223-39, vii
[PMID] 10028123.
1998
Blocking cytokines with genes.
Journal of leukocyte biology.
64(1):55-61
[PMID] 9665275.
1998
Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects.
Proceedings of the National Academy of Sciences of the United States of America.
95(8):4613-8
[PMID] 9539786.
1998
Gene therapy in autoimmune diseases.
Annals of the rheumatic diseases.
57(3):125-7
[PMID] 9640124.
1998
Viral vectors for gene therapy.
Pharmacology & therapeutics.
80(1):35-47
[PMID] 9804053.
1998
Viral vectors for gene therapy.
Trends in biotechnology.
16(1):35-40
[PMID] 9470229.
1997
Constitutive intra-articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis.
Journal of immunology (Baltimore, Md. : 1950).
159(7):3604-12
[PMID] 9317160.
1997
Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: implications for arthritis gene therapy.
Gene therapy.
4(9):977-82
[PMID] 9349435.
1997
Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study.
Osteoarthritis and cartilage.
5(2):139-43
[PMID] 9135825.
1997
Gene therapy for arthritis: principles and clinical practice.
Biochemical Society transactions.
25(2):533-7
[PMID] 9191150.
1996
Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis.
Human gene therapy.
7(10):1261-80
[PMID] 8793551.
1996
Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo.
Arthritis and rheumatism.
39(5):820-8
[PMID] 8639179.
1996
Genomic footprinting of mitochondrial DNA: I. In organello analysis of protein-mitochondrial DNA interactions in bovine mitochondria.
Methods in enzymology.
264:12-22
[PMID] 8965685.
1996
Genomic footprinting of mitochondrial DNA: II. In vivo analysis of protein-mitochondrial DNA interactions in Xenopus laevis eggs and embryos.
Methods in enzymology.
264:23-36
[PMID] 8965697.
1994
In organello footprint analysis of human mitochondrial DNA: human mitochondrial transcription factor A interactions at the origin of replication.
Molecular and cellular biology.
14(12):7717-30
[PMID] 7969115.
1993
In organello footprinting. Analysis of protein binding at regulatory regions in bovine mitochondrial DNA.
The Journal of biological chemistry.
268(12):8675-82
[PMID] 8473311.
1993
In vivo and in vitro evidence for slipped mispairing in mammalian mitochondria.
Proceedings of the National Academy of Sciences of the United States of America.
90(16):7671-5
[PMID] 8356068.
1993
Protein binding to a single termination-associated sequence in the mitochondrial DNA D-loop region.
Molecular and cellular biology.
13(4):2162-71
[PMID] 8455604.
1993
Transcribed heteroplasmic repeated sequences in the porcine mitochondrial DNA D-loop region.
Journal of molecular evolution.
37(1):36-7
[PMID] 8360917.
Grants
Sep 2022
– Aug 2024
Novel?coated?nanostructured implant surfaces to increase osseointegration and decrease peri-implantitis in a physiologic rat model
Role: Co-Investigator
Funding: NATL INST OF HLTH NIDCR
Aug 2019
ACTIVE
Development of a Novel AAV Vector Capsid Optimized for OA Gene Therapy
Role: Principal Investigator
Funding: US ARMY MED RES ACQUISITION
Jun 2018
– Nov 2021
OR-DRPD-ROF2018: Developing a Novel In Vitro Model of Osteosarcoma by 3D printing in Liquid-Like Solids
Role: Co-Investigator
Funding: UF RESEARCH
May 2018
ACTIVE
High throughput 3D printing
Role: Project Manager
Funding: MERCK SHARP & DOHME
Jun 2016
– Sep 2021
Novel coatings to minimize surface degradation and fracture susceptibility of dental ceramics
Role: Project Manager
Funding: NATL INST OF HLTH NIDCR
Aug 2014
– Sep 2018
Gene Therapy for Post Traumatic Osteoarthritis
Role: Principal Investigator
Funding: US ARMY MED RES ACQUISITION
Jul 2014
– Jun 2016
Development of AAV Vectors for Efficient Targeting and Elimination of Osteosarcoma Tumor-Initiating Cells
Role: Principal Investigator
Funding: ALEXS LEMONADE STAND FOUNDATION
Aug 2010
– May 2016
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia
Role: Principal Investigator
Funding: NATL INST OF HLTH NIAMS
Jul 2007
– Aug 2016
Clinical and Translational Science Institute
Role: Project Manager
Funding: UF RESEARCH FOU
Contact Details
Phones:
- Business:
- (352) 273-7059
Emails:
- Business:
- ghivisc@ortho.ufl.edu
Addresses:
- Business Mailing:
-
PO BOX 100137
GAINESVILLE FL 326100001 - Business Street:
-
ROOM M2-210 -212, JHMHC
1600 SW ARCHER RD
GAINESVILLE FL 32610